Evidence map›Paper›PMID 38371808›Full record

ArticleACS omega2024

Diterpenoid Tanshinones Can Inhibit Lung Cancer Progression by Improving the Tumor Microenvironment and Downregulation of NF-κB Expression.

Hao Xu, Ning Ning Guo, Chen Ying Zhu, Lin Yan Ye, Xing Yi Yan, Yong Qin Liu, Ze Yan Zhang, Guangji Zhang, Liaqat Hussain

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Pharmacological Evaluation ofCurrent cancer drug targets · 2026
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Hao XuCollege of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, P. R. China.
Ning Ning GuoInner Mongolia Medical University, Inner Mongolia, Hohhot 010110, P. R. China.
Chen Ying ZhuDepartment of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, P. R. China.
Lin Yan YeDepartment of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, P. R. China.
Xing Yi YanDepartment of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, P. R. China.
Yong Qin LiuDepartment of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, P. R. China.
Ze Yan ZhangDepartment of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, P. R. China.
Guangji ZhangCollege of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, P. R. China.
Liaqat HussainDepartment of Pharmacology, Faculty of Pharmaceutical Science, Government College University, Faisalabad 38000, Pakistan.ORCID https://orcid.org/0000-0001-7171-5917
Zhejiang University · CNZhejiang Chinese Medical University · CNGovernment College University, Faisalabad · PKInner Mongolia Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diterpenoid tanshinones (DTs) are a bioactive fraction extracted from

Identifiers

PMID38371808
PMCPMC10870295
OpenAlexW4391476112

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.